Blueprint Medicines (BPMC) Up 8.7% Since Last Earnings Report: Can It Continue?

It has been about a month since the last earnings report for Blueprint Medicines (BPMC) . Shares have added about 8.7% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Blueprint Medicines due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. BPMC Beats on Q3 Earnings and S ...